Sujay Jadhav

What Can We Expect in Pharma in 2023?

Drug pricing, CMS getting negotiating power for drug purchasing, vaccines, clinical trials, artificial intelligence, and Pharmacists becoming care givers. These are the highlights of 2022, what do the experts say we will see in 2023? We rounded up some experts and asked them just that.

Read More

HIMSS22: Reactions and Takeaways

With the reporting of 26,000 attendees, HIMSS seems to be getting back on track and moving in the right direction. So what were the reactions? What were the takeaways? Will the exhibitors and attendees return next year? Here is what they told us.